Skip to main content
. 2021 Dec 28;77(3):301–307. doi: 10.1016/j.therap.2021.12.015

Table 2.

Comparison of frequencies of events between the 2 periods (incidence >2%).

SOCm Number of ADRs (%)
“pre-COVID”
Number of ADRs (%)
“COVID”
Cutaneous disorders* 885 (32.5%) 22(6.3%)
Neurological disorders* 251 (9.2%) 7 (2%)
Haematological disorders* 236 (8.7%) 9 (2.6%)
Eye disorders* 211 (7.7%) 7 (2.0%)
Gastrointestinal disorders 183 (6.7%) 33 (9.4%)
General disorders* 136 (5.0%) 7 (2.0%)
Cardiac disorders* 128 (4.7%) 199 (56.7%)
Hepatobiliary disorders* 121 (4.4%) 37 (10.5%)
Musculoskeletal disorders* 101 (3.7%) 1 (0.3%)
Hearing disorders* 74 (2.7%) 1 (0.3%)
Infections 71 (2.6%) 4 (1.1%)
Psychiatric disorders 65 (2.4%) 3 (0.9%)
Metabolic disorders* 30 (1.1%) 10 (2.8%)
Others 235 (8.6%) 11 (3.1%)

ADR: adverse drug reactions; COVID: coronavirus disease; SOC: system organ class.

*

P < 0.05.